Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04218617 · ClinicalTrials.gov registry record · Phase 2
Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases
A Phase 2 study of Spine Metastases and Spine Stereotactic Radiosurgery (sSRS), sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT04218617 is a Phase 2 study of Spine Metastases and Spine Stereotactic Radiosurgery (sSRS) that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 130 participants, below the 474-participant average among 7 other Spine Metastases trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04218617, a Phase 2 study of Spine Metastases and Spine Stereotactic Radiosurgery (sSRS), is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
Spine radiosurgery (SRS) utilizes advanced treatment planning with focused x-rays to deliver one to four high dose treatments to the spine to help relieve pain and/or neurologic symptoms. Spine SRS uses special equipment to position the participant and guide the focused beams toward the area to be treated and away from normal tissue. One of the side effects of spine SRS is the development of vertebral compression fractures, many of which are not painful. The goal of this study is to compare the effects, good and/or bad, of spine SRS given in 1 or 2 treatments. Our main goal is to find out which approach will reduce the chances of developing vertebral compression fractures.
Conditions Studied
Interventions
- DEVICE Diagnostic MRI
- DEVICE Planning MRI
- OTHER Simulation CT
- OTHER QOL assessment
- OTHER Brief pain inventory (BPI)
Study Locations (1)
Ohio
- Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2020-02-07 |
| Est. Completion | 2026-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04218617
The ClinicalTrials.gov registry entry for NCT04218617 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 7 other Spine Metastases trials with a reported enrollment target (73% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Spine Metastases appearing as the primary indexed condition, and to 5 interventions - of which Diagnostic MRI is the first listed.
NCT04218617 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04218617 about?
NCT04218617 is a clinical study titled "Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases". Spine radiosurgery (SRS) utilizes advanced treatment planning with focused x-rays to deliver one to four high dose treatments to the spine to help relieve pain and/or neurologic symptoms. Spine SRS uses special equipment to position the participant and guide the focused beams toward the area to be t...
What is the current status of trial NCT04218617?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 130 participants. The study started on 2020-02-07. Estimated completion is 2026-10.
What conditions does trial NCT04218617 study?
This clinical trial studies the following conditions: Spine Metastases, Spine Stereotactic Radiosurgery (sSRS).
What interventions are being tested in trial NCT04218617?
The interventions under investigation include: Diagnostic MRI (DEVICE), Planning MRI (DEVICE), Simulation CT (OTHER), QOL assessment (OTHER), Brief pain inventory (BPI) (OTHER).
Who is sponsoring clinical trial NCT04218617?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04218617 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spine Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Definitive Radiation for High-Risk Spine Metastases
RECRUITING · Phase 2
-
Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease
RECRUITING · Phase 1
-
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
RECRUITING · NA
-
Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal Column
RECRUITING · NA
-
Spine Oncology Registry
RECRUITING
-
Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.